Logo image of FRPT

FRESHPET INC (FRPT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:FRPT - US3580391056 - Common Stock

60.13 USD
-2.91 (-4.62%)
Last: 12/30/2025, 8:26:21 PM
60.32 USD
+0.19 (+0.32%)
After Hours: 12/30/2025, 8:26:21 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to FRPT. FRPT was compared to 87 industry peers in the Food Products industry. FRPT has only an average score on both its financial health and profitability. FRPT is valued quite expensive, but it does show an excellent growth. With these ratings, FRPT could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

FRPT had positive earnings in the past year.
In the past year FRPT had a positive cash flow from operations.
In the past 5 years FRPT reported 4 times negative net income.
FRPT had a positive operating cash flow in 4 of the past 5 years.
FRPT Yearly Net Income VS EBIT VS OCF VS FCFFRPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

The Return On Assets of FRPT (7.07%) is better than 86.21% of its industry peers.
FRPT has a Return On Equity of 10.48%. This is in the better half of the industry: FRPT outperforms 79.31% of its industry peers.
FRPT has a Return On Invested Capital of 3.28%. This is comparable to the rest of the industry: FRPT outperforms 54.02% of its industry peers.
Industry RankSector Rank
ROA 7.07%
ROE 10.48%
ROIC 3.28%
ROA(3y)-1.53%
ROA(5y)-1.83%
ROE(3y)-1.62%
ROE(5y)-1.96%
ROIC(3y)N/A
ROIC(5y)N/A
FRPT Yearly ROA, ROE, ROICFRPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4

1.3 Margins

The Profit Margin of FRPT (11.44%) is better than 89.66% of its industry peers.
With a decent Operating Margin value of 6.41%, FRPT is doing good in the industry, outperforming 67.82% of the companies in the same industry.
FRPT has a Gross Margin of 40.58%. This is amongst the best in the industry. FRPT outperforms 93.10% of its industry peers.
FRPT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.41%
PM (TTM) 11.44%
GM 40.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.84%
GM growth 5Y-2.62%
FRPT Yearly Profit, Operating, Gross MarginsFRPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FRPT is destroying value.
FRPT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, FRPT has more shares outstanding
FRPT has a better debt/assets ratio than last year.
FRPT Yearly Shares OutstandingFRPT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
FRPT Yearly Total Debt VS Total AssetsFRPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 4.10 indicates that FRPT is not in any danger for bankruptcy at the moment.
FRPT has a Altman-Z score of 4.10. This is amongst the best in the industry. FRPT outperforms 85.06% of its industry peers.
The Debt to FCF ratio of FRPT is 176.25, which is on the high side as it means it would take FRPT, 176.25 years of fcf income to pay off all of its debts.
FRPT has a Debt to FCF ratio (176.25) which is comparable to the rest of the industry.
FRPT has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.36, FRPT is in line with its industry, outperforming 55.17% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 176.25
Altman-Z 4.1
ROIC/WACC0.41
WACC7.9%
FRPT Yearly LT Debt VS Equity VS FCFFRPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 5.52 indicates that FRPT has no problem at all paying its short term obligations.
With an excellent Current ratio value of 5.52, FRPT belongs to the best of the industry, outperforming 94.25% of the companies in the same industry.
A Quick Ratio of 4.61 indicates that FRPT has no problem at all paying its short term obligations.
FRPT has a better Quick ratio (4.61) than 94.25% of its industry peers.
Industry RankSector Rank
Current Ratio 5.52
Quick Ratio 4.61
FRPT Yearly Current Assets VS Current LiabilitesFRPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

7

3. Growth

3.1 Past

FRPT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 196.63%, which is quite impressive.
Looking at the last year, FRPT shows a quite strong growth in Revenue. The Revenue has grown by 16.34% in the last year.
FRPT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.72% yearly.
EPS 1Y (TTM)196.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%675%
Revenue 1Y (TTM)16.34%
Revenue growth 3Y31.84%
Revenue growth 5Y31.72%
Sales Q2Q%14%

3.2 Future

The Earnings Per Share is expected to grow by 21.09% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 10.25% on average over the next years. This is quite good.
EPS Next Y127.26%
EPS Next 2Y24.18%
EPS Next 3Y27.01%
EPS Next 5Y21.09%
Revenue Next Year13.01%
Revenue Next 2Y11.34%
Revenue Next 3Y10.93%
Revenue Next 5Y10.25%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
FRPT Yearly Revenue VS EstimatesFRPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
FRPT Yearly EPS VS EstimatesFRPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 22.78 indicates a rather expensive valuation of FRPT.
FRPT's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 26.77. FRPT is around the same levels.
With a Price/Forward Earnings ratio of 41.48, FRPT can be considered very expensive at the moment.
FRPT's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.35, FRPT is valued quite expensively.
Industry RankSector Rank
PE 22.78
Fwd PE 41.48
FRPT Price Earnings VS Forward Price EarningsFRPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

FRPT's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as FRPT.
Industry RankSector Rank
P/FCF 1209.79
EV/EBITDA 20.52
FRPT Per share dataFRPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

FRPT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as FRPT's earnings are expected to grow with 27.01% in the coming years.
PEG (NY)0.18
PEG (5Y)N/A
EPS Next 2Y24.18%
EPS Next 3Y27.01%

0

5. Dividend

5.1 Amount

No dividends for FRPT!.
Industry RankSector Rank
Dividend Yield 0%

FRESHPET INC

NASDAQ:FRPT (12/30/2025, 8:26:21 PM)

After market: 60.32 +0.19 (+0.32%)

60.13

-2.91 (-4.62%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-03 2025-11-03/bmo
Earnings (Next)02-18 2026-02-18/amc
Inst Owners119.7%
Inst Owner Change-4.02%
Ins Owners1.79%
Ins Owner Change6.55%
Market Cap2.93B
Revenue(TTM)1.08B
Net Income(TTM)123.44M
Analysts77.39
Price Target74.64 (24.13%)
Short Float %12.24%
Short Ratio4.56
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)238.72%
Min EPS beat(2)157.12%
Max EPS beat(2)320.31%
EPS beat(4)2
Avg EPS beat(4)114.73%
Min EPS beat(4)-9.66%
Max EPS beat(4)320.31%
EPS beat(8)6
Avg EPS beat(8)167.24%
EPS beat(12)9
Avg EPS beat(12)116.75%
EPS beat(16)9
Avg EPS beat(16)71.21%
Revenue beat(2)0
Avg Revenue beat(2)-1.76%
Min Revenue beat(2)-3.16%
Max Revenue beat(2)-0.37%
Revenue beat(4)0
Avg Revenue beat(4)-1.7%
Min Revenue beat(4)-3.16%
Max Revenue beat(4)-0.37%
Revenue beat(8)3
Avg Revenue beat(8)-0.27%
Revenue beat(12)5
Avg Revenue beat(12)0.11%
Revenue beat(16)7
Avg Revenue beat(16)-0.09%
PT rev (1m)-2.52%
PT rev (3m)-21.69%
EPS NQ rev (1m)-11.11%
EPS NQ rev (3m)-35.74%
EPS NY rev (1m)100.21%
EPS NY rev (3m)90.87%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-3.66%
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)-0.79%
Valuation
Industry RankSector Rank
PE 22.78
Fwd PE 41.48
P/S 2.72
P/FCF 1209.79
P/OCF 18.84
P/B 2.49
P/tB 2.49
EV/EBITDA 20.52
EPS(TTM)2.64
EY4.39%
EPS(NY)1.45
Fwd EY2.41%
FCF(TTM)0.05
FCFY0.08%
OCF(TTM)3.19
OCFY5.31%
SpS22.12
BVpS24.14
TBVpS24.14
PEG (NY)0.18
PEG (5Y)N/A
Graham Number37.87
Profitability
Industry RankSector Rank
ROA 7.07%
ROE 10.48%
ROCE 4.15%
ROIC 3.28%
ROICexc 3.92%
ROICexgc 3.92%
OM 6.41%
PM (TTM) 11.44%
GM 40.58%
FCFM 0.22%
ROA(3y)-1.53%
ROA(5y)-1.83%
ROE(3y)-1.62%
ROE(5y)-1.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.84%
GM growth 5Y-2.62%
F-Score8
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 176.25
Debt/EBITDA 2.7
Cap/Depr 173.99%
Cap/Sales 14.21%
Interest Coverage 8.38
Cash Conversion 99%
Profit Quality 1.97%
Current Ratio 5.52
Quick Ratio 4.61
Altman-Z 4.1
F-Score8
WACC7.9%
ROIC/WACC0.41
Cap/Depr(3y)442.82%
Cap/Depr(5y)604.48%
Cap/Sales(3y)29.67%
Cap/Sales(5y)41.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)196.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%675%
EPS Next Y127.26%
EPS Next 2Y24.18%
EPS Next 3Y27.01%
EPS Next 5Y21.09%
Revenue 1Y (TTM)16.34%
Revenue growth 3Y31.84%
Revenue growth 5Y31.72%
Sales Q2Q%14%
Revenue Next Year13.01%
Revenue Next 2Y11.34%
Revenue Next 3Y10.93%
Revenue Next 5Y10.25%
EBIT growth 1Y94.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year379.26%
EBIT Next 3Y89.29%
EBIT Next 5Y54.32%
FCF growth 1Y101.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y215.31%
OCF growth 3Y519.17%
OCF growth 5Y56.72%

FRESHPET INC / FRPT FAQ

What is the ChartMill fundamental rating of FRESHPET INC (FRPT) stock?

ChartMill assigns a fundamental rating of 5 / 10 to FRPT.


What is the valuation status of FRESHPET INC (FRPT) stock?

ChartMill assigns a valuation rating of 3 / 10 to FRESHPET INC (FRPT). This can be considered as Overvalued.


How profitable is FRESHPET INC (FRPT) stock?

FRESHPET INC (FRPT) has a profitability rating of 5 / 10.


Can you provide the financial health for FRPT stock?

The financial health rating of FRESHPET INC (FRPT) is 6 / 10.


What is the earnings growth outlook for FRESHPET INC?

The Earnings per Share (EPS) of FRESHPET INC (FRPT) is expected to grow by 127.26% in the next year.